Literature DB >> 6562280

Hemodialysis leukopenia and complement function with different dialyzers.

A Amadori, P Candi, M Sasdelli, G Massai, S Favilla, A Passaleva, M Ricci.   

Abstract

The relationship between leukopenia and the complement system during hemodialysis was re-examined by studying not only the in vivo effects of four different dialyzer membranes (cellulose hydrate, cuprophan, cellulose acetate, and polyacrilonitrile) on leukocyte counts and complement levels, but especially by investigating the effects of these membranes on complement function in vitro. Whereas from in vivo studies no definite conclusions could be drawn, in vitro investigations provided clear-cut information. When more sophisticated technical approaches were undertaken, it became evident that hemodialysis leukopenia has to be thought of in terms of chemotactic factor generation. In fact, a strict correlation was demonstrated between the degree of leukopenia induced by the dialyzers tested and the ability of the relative membrane to generate chemotactic activity in vitro. Moreover, the previously observed ability of polyacrilonitrile membrane to induce a decrement in complement function was due to the ability of polyacrilonitrile to adsorb complement activity and did not correspond to effective complement consumption. This finding explained why polyacrilonitrile dialysis is not accompanied by a decrease in circulating granulocytes. Taken together, our data strongly point to a pivotal role of complement system in the pathogenesis of hemodialysis leukopenia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6562280     DOI: 10.1038/ki.1983.227

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.

Authors:  P Hardouin; R M Flipo; P Foissac-Gegoux; A Dumont; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

3.  Human complement protein D catabolism by the rat kidney.

Authors:  P W Sanders; J E Volanakis; S G Rostand; J H Galla
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

4.  Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes.

Authors:  A R Rosenkranz; E Templ; O Traindl; H Heinzl; G J Zlabinger
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

Review 5.  Artificial Kidney Engineering: The Development of Dialysis Membranes for Blood Purification.

Authors:  Yu-Shuo Tang; Yu-Cheng Tsai; Tzen-Wen Chen; Szu-Yuan Li
Journal:  Membranes (Basel)       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.